Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer

HIGHLIGHTS

  • who: Yuji Hakozaki from the , patients who were diagnosed as M CRPC between , and , at the University of have published the Article: Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer, in the Journal: Scientific Reports Scientific Reports
  • what: The aim of this study was to identify prognostic factors for predicting cancer-specific survival (CSS) using clinical data obtained at the time of CRPC diagnosis. The authors aimed to identify prognostic factors of CSS in M0CRPC patients.

SUMMARY

    Factors . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?